Weight loss drug could reduce heart attack risk by 20%, study finds – The Guardian

Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
Wegovy weight loss sustained for four years in trial, Novo Nordisk says Reuters
Obesity drug shows significant weight loss for at least four years, with fewer serious events, study finds Sky News

Brought to you by Google News. Read the rest of the article here.